A man in Lucknow City in Northern India filed a lawsuit against the CEO of Serum Institute of India and seven others, claiming that he did not develop antibodies after taking the first dose of the Covishield vaccine.
Covishield vaccine is made from a virus (ChAdOx1), a weakened version of a common cold virus (adenovirus) from chimpanzees. The genetic material has been added to the ChAdOx1 construct, which is used to make proteins from the SARS-CoV-2 coronavirus called Spike glycoprotein (S).
This vaccine is the same formulation as the Oxford/AstraZeneca vaccine (AZD1222). Serum Institute of India is the world’s largest manufacturer by the number of doses produced and sold globally.
Pratap Chandra, said in his complaint that he received the first dose of Covishield on April 8 and he feel unwell afterward.
He took a Covid Antibody GT test from a government-approved lab and revealed that he did not develop any antibodies against Covid-19. Instead, his platelet counts were reduced by half and now he is more at risk of the virus.
India Today reported:
Lucknow District and Sessions Court has summoned seven people on April 1, including Serum Institute of India CEO Adar Poonawalla, in a case filed over alleged non-production of antibodies after the first dose of Covishield.
The complainant, Pratap Chandra, said in the complaint that he received the first dose of Covishield on April 8. Chandra said he was supposed to receive the second dose 28 days later but on the said day he was told that the date for the second dose had been extended by six weeks. Later, the government revised the time gap between the two doses to 12 weeks.
Chandra said he was not feeling well after receiving the first jab. Citing ICMR director general Balram Bhargav’s quotes in media where he had said “good levels of antibodies are produced in the body after the first dose of Covishield”, the complainant took a Covid Antibody GT test from a government-approved lab.
The test result revealed that the complainant did not develop any antibodies against Covid-19, instead his platelets were reduced to 1.5 lakh from 3 lakh.
Chandra alleged that after taking the vaccine he has become more prone to the virus as his platelet count has been reduced by half.
The post Man Files Lawsuit Over Alleged Non-Production of Antibodies After Receiving First Dose of AstraZeneca’s COVISHIELD appeared first on The Gateway Pundit.
